tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

ProQR Therapeutics sees cash runway into mid-2026

At June 30, 2024, ProQR held cash and cash equivalents and short term financial assets of EUR 96.2 million, compared to EUR 118.9 million cash and cash equivalents at December 31, 2023. Net cash used in operating activities during the three-month period ended June 30, 2024 was EUR 6.3 million, compared to EUR 10.3 million used for the same period last year

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1